Target intelligence / Profile preview

DNA and cell division machinery

Molecular classification
Nucleic acid, Enzyme, Cytoskeletal protein, Kinase
01

Overview

DNA and cell division machinery encompasses the integrated network of proteins and nucleic acids responsible for genome replication and the physical partitioning of cellular components during mitosis [Nature Reviews Molecular Cell Biology, 2011]. This machinery includes DNA, which serves as the template, and various enzymes such as DNA polymerases and topoisomerases that facilitate replication and relieve torsional strain [NCBI, 2023]. Additionally, the mitotic spindle, primarily composed of tubulin, is a critical structural component that ensures accurate chromosome segregation [StatPearls, 2023]. In clinical practice, this machinery is the target of numerous cytotoxic agents used to treat cancer by inducing cell cycle arrest or apoptosis in rapidly dividing cells [National Cancer Institute, 2024]. Drugs like cisplatin cross-link DNA, while taxanes stabilize microtubules to prevent the completion of mitosis [PubChem, 2024]. Because these processes are fundamental to all eukaryotic cells, therapeutic intervention often results in off-target toxicity to healthy, proliferating tissues such as the hematopoietic system [American Cancer Society, 2024].

Other names
Cell cycle machineryDNA replication and mitotic apparatusProliferation machineryMitotic machinery
02

Mechanism of action

The mechanism of action involves the disruption of genomic integrity or the physical apparatus of division. This includes direct DNA damage through alkylation or intercalation, inhibition of DNA synthesis via antimetabolites, and the interference with microtubule dynamics or topoisomerase activity, ultimately leading to cell cycle arrest and programmed cell death [StatPearls, 2023; PubChem, 2024].

03

Biological functions

DNA replicationMitosisCell cycle progressionCytokinesis
04

Disease associations

CancerInfectious diseaseAutoimmune disease
05

Safety considerations

MyelosuppressionGastrointestinal toxicityAlopeciaTeratogenicitySecondary malignanciesCardiotoxicity
06

Interacting drugs

Cisplatin

6 more in the full profile.

07

Biomarkers

Ki-67BRCA1/2 mutationsMicrosatellite instability (MSI)TP53 mutation status

Beyond the preview

Go deeper on DNA and cell division machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA and cell division machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call